The federal government in Australia has announced that Pfizer's atorvastatin [Lipitor] warrants a higher price than Merck & Co's simvastatin [Zocor] for Pharmaceutical Benefits Scheme (PBS) subsidy
Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.483, 2005-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Access to resources
Recommend
